Upcoming AWS Coverage on Intrepid Potash Post-Earnings Results

LONDON, UK / ACCESSWIRE / March 20, 2017 / Active Wall St. blog coverage looks at the headline from Syngenta AG (NYSE: SYT) as the Company announced on March 17, 2017, that the German authorities have approved the SDHI fungicide SOLATENOL?, thereby extending its registration further in Europe. The recent registration will allow the Company to launch the products ELATUS? Era and ELATUS? Plus to the cereals market in Germany. Syngenta stated that ELATUS? Plus is a solo formulation of the active ingredient SOLATENOLTM and is sold in co-packs with a range of other products. Syngenta's ELATUS? Era is a combination of the two active ingredients SOLATENOLTM and prothioconazole. Register with us now for your free membership and blog access at:

http://www.activewallst.com/register/

One of Syngenta's competitors within the Agricultural Chemicals space, Intrepid Potash Inc. (NYSE: IPI), reported on February 28, 2017, its financial results for the fourth quarter and full year 2016. AWS will be initiating a research report on Intrepid Potash in the coming days.

Today, AWS is promoting its blog coverage on SYT; touching on IPI. Get all of our free blog coverage and more by clicking on the link below:

http://www.activewallst.com/register/

SOLATENOL? is already registered in France, Croatia, UK, Ireland, Finland, Latvia, Estonia, and Austria. The launch of SOLATENOL? in Germany for the 2017 season gives growers in another major cereals market access to this leading new technology.

What is SOLATENOL?

SOLATENOL? is a carboxamide fungicide offering better performance against Septoria and rusts - two important diseases which can significantly impact cereals production. In trials, it has proven to be extremely consistent in providing excellent disease control on all important cereals varieties in a wide range of situations over several years. The product offers outstanding levels of leaf protection resulting in higher yield and return on investment for the farmer. SOLATENOL? is also available for use on soybean in Latin America and on a wide range of crops in the USA and Canada.

ChemChina Transaction

On February 23, 2017, China National Chemical Corporation ("ChemChina") announced that it has extended the tender offers to purchase all publicly held registered shares of Syngenta and all outstanding American Depositary Shares representing common shares until April 28, 2017, unless further extended.

On February 03, 2016, ChemChina announced its agreement with Syngenta to acquire Syngenta through a public tender offer for all publicly held common shares pursuant to Swiss tender offer rules and a public tender offer for common shares held by US holders and all outstanding ADSs pursuant to US tender offer rules. ChemChina has extended the Swiss Offer until 4:00 p.m. CEST, on April 28, 2017, and the US Offer until 10:00 a.m., Eastern Time, on April 28, 2017, in each case, unless further extended. As of 5:00 p.m., Eastern Time, on February 21, 2017, approximately 19,557,444 common shares (including those represented by ADSs) had been validly tendered in, and not withdrawn from, the Offers.

On March 06, 2017, as per a report by Reuters, ChemChina announced that Chinese government has accepted the Company's application for regulatory approval of its $43 billion takeover of Syngenta.

Stock Performance

At the closing bell on Friday, March 17, 2017, Syngenta's stock marginally declined 0.23%, ending the trading session at $88.28. A total volume of 887.38 thousand shares were traded at the end of the day, which was higher than the 3-month average volume of 608.77 thousand shares. In the last month and previous three months, shares of the Company have advanced 2.88% and 10.43%, respectively. Moreover, the stock surged 11.68% since the start of the year. Shares of the company have a PE ratio of 34.34 and have a dividend yield of 2.59%

Active Wall Street:

Active Wall Street (AWS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. AWS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

AWS has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst, for further information on analyst credentials, please email info@activewallst.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by AWS. AWS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

AWS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. AWS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, AWS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither AWS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.activewallst.com/disclaimer/.

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@activewallst.com

Phone number: 1-858-257-3144

Office Address: 3rd floor, 207 Regent Street, London, W1B 3HH, United Kingdom

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Active Wall Street